Open Access Influence of 70 nm silica particles in mice with cisplatin or paraquat-induced toxicity

Authors: Nishimori, H.1; Kondoh, M.2; Isoda, K.1; Tsunoda, S.3; Tsutsumi, Y.4, 3; Yagi, K.1

Source: Die Pharmazie - An International Journal of Pharmaceutical Sciences, Volume 64, Number 6, 1 June 2009 , pp. 395-397(3)

Publisher: Govi-Verlag

Buy & download fulltext article:

Open Access The full text is Open Access.

View now:
PDF 92.4kb 

Abstract:

In the pharmaceutical industry, nano-size materials are designed as drug carriers and diagnosis probes. Interactions between nano-size materials and chemicals need investigating. Here, we investigated whether nano-size materials affect chemical-induced toxicity using silica particles, which have been widely used in cosmetics and drug delivery and have diameters of 70 (SP70), 300 (SP300) and 1000 (SP1000) nm, a popular anti-tumor agent, cisplatin, and a widely used herbicide, paraquat. Mice were treated with either cisplatin (100 μmol/kg, intraperitoneally) or paraquat (50 mg/kg, intraperitoneally), with or without intravenous silica particle administration. All treatments were non-lethal and did not show severe toxicity, except for injection with both cisplatin and SP70, which were lethal. When mice received with paraquat and/or the silica particles, synergistic enhanced toxicity was observed in both paraquat- and SP70-treated mice. These synergic effects were not observed with either Si300 or 1000 treatment. Our findings suggest that further evaluation on the interaction between nano-size materials and chemicals is critical for the pharmaceutical application of nanotechnology.

Document Type: Research article

DOI: http://dx.doi.org/10.1691/ph.2009.9048

Affiliations: 1: Laboratory of Bio-Functional Molecular Chemistry, Graduate School of Pharmaceutical Sciences, Osaka University, Suita, Osaka, Japan 2: Laboratory of Bio-Functional Molecular Chemistry, Graduate School of Pharmaceutical Sciences, Osaka University, Suita, Osaka, 565-0871, Japan, Email: masuo@phs.osaka-u.ac.jp 3: Laboratory of Pharmaceutical Proteomics, Division of Biomedical Research, National Institute of Biomedical Innovation, Ibaraki, Osaka, Japan 4: Laboratory of Toxicology, Graduate School of Pharmaceutical Sciences, Osaka University, Suita, Osaka, Japan

Publication date: 2009-06-01

More about this publication?
  • Pharmazie is one of the world's leading pharmaceutical journals. As a peer-reviewed scientific journal, DiePharmazie is regularly indexed in Current Contents/Life Sciences, Excerpta Medica, Analytical Abstracts, International Pharmaceutical Abstracts, Beilstein Current Facts in Chemistry, Chemical Engineering and Biotechnology Abstracts (CEABA) and Science Citation Index.
  • Information for Authors
  • Submit a Paper
  • Subscribe to this Title
  • Terms & Conditions
  • ingentaconnect is not responsible for the content or availability of external websites
Related content

Tools

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page